AR226806A1 - Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienos - Google Patents

Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienos

Info

Publication number
AR226806A1
AR226806A1 AR270418A AR27041877A AR226806A1 AR 226806 A1 AR226806 A1 AR 226806A1 AR 270418 A AR270418 A AR 270418A AR 27041877 A AR27041877 A AR 27041877A AR 226806 A1 AR226806 A1 AR 226806A1
Authority
AR
Argentina
Prior art keywords
pregnadiene
pregnene
dioxo
halo
alpha
Prior art date
Application number
AR270418A
Other languages
English (en)
Spanish (es)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Application granted granted Critical
Publication of AR226806A1 publication Critical patent/AR226806A1/es

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AR270418A 1976-12-22 1977-12-19 Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienos AR226806A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (1)

Publication Number Publication Date
AR226806A1 true AR226806A1 (es) 1982-08-31

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
AR270418A AR226806A1 (es) 1976-12-22 1977-12-19 Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienos

Country Status (20)

Country Link
JP (1) JPS604198B2 (fr)
AR (1) AR226806A1 (fr)
AT (2) AT373269B (fr)
BE (1) BE862089A (fr)
DE (1) DE2756550C2 (fr)
DK (1) DK153494C (fr)
FI (1) FI63947C (fr)
FR (1) FR2384793A1 (fr)
GB (1) GB1575983A (fr)
HK (1) HK584A (fr)
HU (1) HU179784B (fr)
IE (1) IE45950B1 (fr)
IL (1) IL53636A (fr)
MY (1) MY8500082A (fr)
NL (1) NL180479C (fr)
NO (1) NO151826C (fr)
NZ (1) NZ186031A (fr)
PT (1) PT67432B (fr)
SE (1) SE429865B (fr)
SG (1) SG58683G (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (zh) 2017-10-02 2019-04-26 爱科来株式会社 糖化蛋白质的测定

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
NL180479C (nl) 1987-03-02
DE2756550C2 (de) 1986-10-16
NL7714056A (nl) 1978-06-26
JPS5379850A (en) 1978-07-14
IL53636A (en) 1983-05-15
FI63947C (fi) 1983-09-12
ATA575980A (de) 1982-04-15
DE2756550A1 (de) 1978-07-06
DK153494C (da) 1989-02-20
BE862089A (fr) 1978-06-20
FR2384793A1 (fr) 1978-10-20
HU179784B (en) 1982-12-28
SE429865B (sv) 1983-10-03
MY8500082A (en) 1985-12-31
JPS604198B2 (ja) 1985-02-01
IE45950L (en) 1978-06-22
PT67432B (en) 1979-05-23
ATA909477A (de) 1983-05-15
SG58683G (en) 1985-01-11
FR2384793B1 (fr) 1981-11-13
FI63947B (fi) 1983-05-31
NO151826B (no) 1985-03-04
AT373269B (de) 1984-01-10
PT67432A (en) 1978-01-01
SE7714538L (sv) 1978-06-23
NL180479B (nl) 1986-10-01
DK153494B (da) 1988-07-18
IE45950B1 (en) 1983-01-12
AT377566B (de) 1985-04-10
NO151826C (no) 1985-06-12
HK584A (en) 1984-01-13
IL53636A0 (en) 1978-03-10
GB1575983A (en) 1980-10-01
FI773825A (fi) 1978-06-23
DK569977A (da) 1978-09-28
NO774359L (no) 1978-06-23
NZ186031A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
AR215000A1 (es) Procedimiento para la preparacion de c-076
AR222007A1 (es) Procedimiento para la preparacion de nuevos hentriacontapeptidos
MX6046E (es) Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles
ES496442A0 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina
MX4089E (es) Procedimiento mejorado para la preparacion de n-fosfonometilglicina
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
AR220683A1 (es) Procedimiento para la preparacion de m-fenoxibenzaldehido
AR215875A1 (es) Procedimiento para la prepararacion de meta-fenoxi-benzaldehido
AR220684A1 (es) Metodo para la preparacion de 1-fenil-3-azabiciclo(3.1.0)hexanos
MX6242E (es) Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
MX4972E (es) Procedimiento mejorado para la preparacion de 7 beta-oxiimmino-acilcefalosporinas
MX4820E (es) Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d
ES456483A0 (es) Procedimiento para la preparacion de compuestos de estilbeno.
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
AR213430A1 (es) Procedimiento para la preparacion de nuevas n-cianoalquil-p-halofenoxi-isobutiramidas
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
ES491683A0 (es) Procedimiento para la preparacion de 1,3,7-trialquilxantinas
RO75589A (fr) Procede pour la preparation du 2,6-methane-2h-1-benzoxocine
MX5685E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tio-substituido)-pirrol
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
MX4750E (es) Procedimiento para la preparacion de gamma-pironas
AR230642A1 (es) Procedimiento para la preparacion de un indoledihidroindolcarboxamida dimerica
MX147640A (es) Procedimiento para la preparacion de compuestos de 4 6-5-beta-sulfatoetilsulfonil-2-amino-fenol
MX4770E (es) Procedimiento mejorado para la preparacion de trans-3,3,5-trimetilciclohexil etileter